drugset / Trial / NCT01178372

Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis

NCT01178372

Summary

Hepatic encephalopathy (HE), a challenging complication of advanced liver disease, occurs in approximately 30-45% of patients with cirrhosis. The treatment of choice is non-absorbable disaccharides, such as lactulose and lactitol.Probiotics are effective in the treatment of minimal hepatic encephalopathy which precipitates hepatic encephalopathy. The investigators will assess the effects of lactulose and probiotics for the prevention of recurrence of HE (secondary prophylaxis) in patients after the recovery of an episode of overt hepatic encephalopathy.

Timeline

Start
2008-09
Primary completion
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactulose Other / unclassified 30 ml
Comparator Lactulose Other / unclassified 60 ml
Comparator VSL#3 Other / unclassified 1.1e+11 unknown